Healthcare provider profile · identity verified

Michele A Despreaux

Internal Medicine · RENTON, WA · NPI 1346326147

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	582	161
Levothyroxine Sodium	Levothyroxine Sodium	533	135
Amlodipine Besylate	Amlodipine Besylate	434	111
Lisinopril	Lisinopril	309	89
Sertraline Hcl	Sertraline Hcl	297	65
Metoprolol Succinate	Metoprolol Succinate	288	80
Furosemide	Furosemide	276	69
Losartan Potassium	Losartan Potassium	247	67
Gabapentin	Gabapentin	237	66
Simvastatin	Simvastatin	231	48
Pantoprazole Sodium	Pantoprazole Sodium	178	47
Eliquis	Apixaban	177	48
Trazodone Hcl	Trazodone Hcl	170	46
Omeprazole	Omeprazole	150	41
Hydrochlorothiazide	Hydrochlorothiazide	145	46
Pravastatin Sodium	Pravastatin Sodium	121	30
Donepezil Hcl	Donepezil Hcl	118	25
Potassium Chloride	Potassium Chloride	118	33
Metformin Hcl	Metformin Hcl	114	39
Carvedilol	Carvedilol	111	26
Rosuvastatin Calcium	Rosuvastatin Calcium	107	39
Metformin Hcl Er	Metformin Hcl	97	28
Duloxetine Hcl	Duloxetine Hcl	94	24
Meloxicam	Meloxicam	94	30
Famotidine	Famotidine	93	23
Montelukast Sodium	Montelukast Sodium	86	18
Albuterol Sulfate Hfa	Albuterol Sulfate	85	41
Oxycodone Hcl	Oxycodone Hcl	85	20
Allopurinol	Allopurinol	75	21
Citalopram Hbr	Citalopram Hydrobromide	74	23
Venlafaxine Hcl Er	Venlafaxine Hcl	74	16
Alendronate Sodium	Alendronate Sodium	69	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	28
Xarelto	Rivaroxaban	68	suppressed
Buspirone Hcl	Buspirone Hcl	66	19
Lovastatin	Lovastatin	65	17
Triamcinolone Acetonide	Triamcinolone Acetonide	65	23
Ropinirole Hcl	Ropinirole Hcl	63	13
Tamsulosin Hcl	Tamsulosin Hcl	63	23
Jardiance	Empagliflozin	61	19
Lorazepam	Lorazepam	61	18
Myrbetriq	Mirabegron	60	suppressed
Fluticasone Propionate	Fluticasone Propionate	59	25
Ozempic	Semaglutide	58	suppressed
Mirtazapine	Mirtazapine	56	11
Atenolol	Atenolol	55	16
Fluoxetine Hcl	Fluoxetine Hcl	53	14
Baclofen	Baclofen	50	12
Chlorthalidone	Chlorthalidone	50	14
Metoprolol Tartrate	Metoprolol Tartrate	50	14
Tramadol Hcl	Tramadol Hcl	50	15
Glimepiride	Glimepiride	49	suppressed
Ipratropium Bromide	Ipratropium Bromide	46	12
Estradiol	Estradiol	45	22
Valsartan	Valsartan	44	suppressed
Ezetimibe	Ezetimibe	43	15
Incruse Ellipta	Umeclidinium Bromide	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Escitalopram Oxalate	Escitalopram Oxalate	42	15
Nystatin	Nystatin	42	suppressed
Telmisartan	Telmisartan	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	15
Tizanidine Hcl	Tizanidine Hcl	40	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	14
Synthroid	Levothyroxine Sodium	39	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	11
Clopidogrel	Clopidogrel Bisulfate	37	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Risperidone	Risperidone	36	suppressed
Lamotrigine	Lamotrigine	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	12
Cephalexin	Cephalexin	34	31
Zolpidem Tartrate	Zolpidem Tartrate	34	11
Paroxetine Hcl	Paroxetine Hcl	33	11
Aripiprazole	Aripiprazole	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Finasteride	Finasteride	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Mupirocin	Mupirocin	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	18
Oxcarbazepine	Oxcarbazepine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	11
Azelastine Hcl	Azelastine Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	12
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Colchicine	Colchicine	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Prednisone	Prednisone	18	12
Acyclovir	Acyclovir	17	suppressed
Diazepam	Diazepam	17	suppressed
Digoxin	Digoxin	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Methenamine Hippurate	Methenamine Hippurate	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Torsemide	Torsemide	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Azithromycin	Azithromycin	14	13
Celecoxib	Celecoxib	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Glipizide	Glipizide	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ulticare Safety Pen Needle	Pen Needle, Diabetic, Safety	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Crestor	Rosuvastatin Calcium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nyamyc	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error